That's dropped down to 30, 35 or 40 at this point
If any of these conditions are not met, the risk to the patient outweighs any potential benefit regardless of the outcome being sought
Pharmacokinetic Parameters Clinical Uses Monotherapy in T2DM when diet and exercise alone are insufficient Combination therapy with metformin, sulfonylureas, or insulin Particularly useful in patients at risk of hypoglycemia or needing once-daily dosing Adverse Effects Typically well tolerated Possible nasopharyngitis, headache, upper respiratory symptoms Rare: pancreatitis, hypersensitivity reactions Low risk of hypoglycemia when used alone Comparative Analysis MCQs Januvia inhibits which enzyme
an enzyme involved in the synthesis of glutamate by some bacteria
Why Eli Lilly Emerged as the GLP-1 Market Leader Eli Lillys rise to the top of the GLP-1 field is due to a combination of blockbuster sales, smart R&D strategy, and aggressive expansion all timed with the soaring demand for new weight-loss therapies
